UBS Group
AGN

UBS Group’s Allergan Inc AGN Stock Holding History

UBS Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-200
Closed -$43K – 10268
2014
Q4 		$43K Buy
+200
New +$39.8K ﹤0.01% 6689

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

UBS Group's AGN Position: Q1 2015 in Review

UBS Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 986,090 shares — an estimated $210M sold.

UBS Group first reported a position in AGN in Q4 2014 and held it in 1 quarter. The position peaked at $210M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • UBS Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • UBS Group sold 986,090 Allergan Inc shares in Q1 2015, an estimated $210M.
  • UBS Group first reported a position in Allergan Inc in Q4 2014 and held it in 1 quarter.
  • UBS Group's Allergan Inc position peaked at $210M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on UBS Group's 13F filing for Q1 2015, filed 14 May 2015.